medigraphic.com
ISSN 0210-5187 (Electronic)

2013, Number 6

<< Back Next >>

Med Cutan Iber Lat Am 2013; 41 (6)

Tuberculous pseudomycetomas. Presentation of eight cases

Pizzariello G, Fernández PP, D’Atri G

Language: Spanish
References: 25
Page: 254-260
PDF size: 555.58 Kb.


ABSTRACT

The cutaneous tuberculosis (TB) is rare (1-5% are the extrapulmonary forms), and the pseudomycetoma, as a form of cutaneous TB, is still more rare and not well recognized as a special form of cutaneous TB. It is not included in the current classifications skin TB.. The aim of this study is to report our experience on this entity.
Material and Methods: Ee had reviewed the medical records of patients who completed the inpatient Hospital Dermatology Service F. J. Muñiz for a period of 35 years, and selected those that had a diagnosis of tuberculous pseudomycetoma.
Results: We confirmed the diagnosis in eight cases. The mean age of the subjects was 40 years, with male predominance. The median time to progression was 24 months, and the most common location were lower limb (foot). Five individuals had a history of a evident previous trauma. Three patients had family members affected with tuberculosis, and in four cases the pseudomycetoma was the only manifestation of the disease. A half of cases showed underlying skin engagement. All patients benefited from the treatment for tuberculosis, although two individuals were required amputation of the affected area because the delate diagnosis.
Comment: Tuberculous pseudomycetoma is a rarity, and has features that differentiate and justify their separation from the rest of cutaneous TB. His knowledge has implications for the prevention of sequelae, mutilation and disability, all of them avoided with an early treatment.


REFERENCES

  1. World Health Organization. Global Tuberculosis Report 2012. Chapter 2: The burden of disease caused by TB. Año 2012. No figura autores, editorial. Está en la siguiente página de internet www.who.int/tb/publications/global_ report/gtbr12_main.pdf

  2. World Health Organization. Datos estadísticos de Argentina. http://www. who.int/countries/ arg/es/

  3. Consenso Argentino de Tuberculosis. Abbate E, Ballester D, Barrera L, Brian MC et al. Rev Arg Med Resp 2009; 9: 61-99.

  4. Gatti JC, Cardama J, Pizzariello G. A propósito de las tuberculosis cutáneas. Ed. P. Cassará. Buenos Aires; 1984: 1-40.

  5. Lai-Cheong JE, Perez A, Tang V, Martinez A, Hill V and Menagé H du P. Cutaneous manifestations of tuberculosis. Clin Exp Dermatol 2007; 32: 461-6.

  6. Villoldo MS, Graciano S, Olivares L, Anaya J, Pizzariello G. Tuberculosis cutánea: formas combinadas. Dermatol Argen 2006; 12: 199-204.

  7. Almaguer-Chávez J, Ocampo-Candiani J, Rendón A. Panorama actual en el diagnóstico de la tuberculosis cutánea. Actas Dermosifiliogr 2009; 100: 562-70.

  8. García-Rodríguez JF, Monteagudo-Sánchez B, Mariño-Callejo A. Cutaneous tuberculosis: a 15-year descriptive study. Enferm Infecc Microbiol Clin 2008; 26: 205-11.

  9. Yates VM, Ormerod LP. Cutaneous tuberculosis in Blackburn district (UK): a 15-year prospective series, 1981-1995. Br J Dermatol 1997; 136: 483-9.

  10. Gatti JC, Cardama JE, Pizzariello GEA, Gandini NI, Gil J. A propósito de las tuberculosis cutáneas. Med Cutan Iber Lat Am 1982; 10: 55-62.

  11. Cabrera HN, Gatti, JC, Avila JJ, Bianchi O. Tuberculosis exóticas. Rev Arg Derm 1972; 56: 17.

  12. Lasa MF, Sturno M, Alonso R, Maldonado S, Forero O, Pizzariello G, Olivares L. Tuberculosis cutánea: revisión de diez años. Dermatol Argen 2000; 6: 375-86.

  13. Cabrera HN, Gabrielli M, Gaviglio AM, Cazenave J. Seudomicetomas tuberculosos. Dermatología Rev Mex 1975; 19: 19-25.

  14. Pueyo ST, González B, Díaz Saubidet J, Rainiero A. Pseudomicetoma tuberculoso en la planta del pie en un niño. Arch Argent Dermatol 1998; 48: 29-31.

  15. Woscoff A, Kaminsky A, Marini M, Allevato M. Dermatología en Medicina Interna. 3º ed. Editorial Alfaomega. Buenos Aires. 2010, pp. 341-8.

  16. Cabrera HN, Gatti CF. Dermatología de Gatti- Cardama. 12a ed. Editorial El Ateneo, Buenos Aires, 2003, pp. 181-90.

  17. Palmero D, Cragnolini de Casado C, Castagnino J, Musella RM. Guías de diagnóstico, tratamiento y prevención de la tuberculosis. Hospital Muñiz-Instituto Vaccarezza. 2011. Disponible en: http://www.intramed. net/userfiles/2011/file/Maria/guia_tuberculosis. pdf.

  18. Tan SH, Tan HH, Sun YJ, Goh CL. Clinical utility of PCR in the detection of Mycobacterium tuberculosis in different types of cutaneous tuberculosis and tuberculids. Ann Acad Med Singapore 2001; 30: 3-10.

  19. Ranawaka RR, Abeygunasekara PH, Perera E, Weerakoon HS. Clinico-histopathological correlation and the treatment response of 20 patients with cutaneous tuberculosis. Dermatol Online J 2010; 16: 13.

  20. Min KW, Ko JY, Park CK. Histopathological spectrum of cutaneous tuberculosis and non-tuberculous mycobacterial infections. J Cutan Pathol 2012; 39: 582-95.

  21. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-62.

  22. Beyt Jr BE, Ortbals DW, Santa Cruz DJ, Kobayashi GS, Eisen AZ, Medoff G. Cutaneous mycobacteriosis: analysis of 34 cases with a new classification of the disease. Medicine (Baltimore) 1981; 60: 95-109.

  23. Savin JA, Wilkinson DS. Mycobacterial infections including tuberculosis. Rook A, Wilkinson DS, Ebling EJ et al. eds. Textbook of Dermatology, 5ta. ed. Londres: Blackwell Scientific, 1991: 1033-63.

  24. Tigoulet F, Fournier V, Caumes E. Clinical forms of the cutaneous tuberculosis. Bull Soc Pathol Exot 2003; 96: 362-7.

  25. Bravo FG, Gotuzzo E. Cutaneous tuberculosis. Clinics Dermatol 2007; 25: 173-80.




2020     |     www.medigraphic.com